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Background
The assessment of newly acquired human immunodefi-
ciency virus type 1 (HIV-1) infection, or incidence, pro-
vides important information for public health programs
and is crucial for understanding the status of the epidemic
and providing information regarding the impact of preven-
tion measures. The aim of this study was to evaluate the
ability of the assay DS-EIA-HIV-AB-TERM correctly iden-
tify long-standing and recent HIV infection in samples
with the preliminary defined time of HIV-1 infection.
Materials and methods
The assay DS-EIA-HIV-AB-TERM intended for the iden-
tification of recently acquired HIV-1 infection was used in
the study. Efficiency assessment of the test was carried out
using serum samples (n=239) with the preliminary defined
time of HIV-1 infection which was identified based on
HIV algorithm testing: recent infection samples (n=150),
long-standing infection (n=89, including samples with a
low CD4+ T cell count) (“Krasnoyarsk Regional center of
AIDS prevention”, “Nizhny Novgorod Regional center of
AIDS prevention”, Russia). Additionally the assay assess-
ment was carried out using seroconversion panels (n=32)
(SeraCare, ZeptoMetrix, USA).
Results
The assay is able to define as recent infection 100% of
samples with seroconversion profile. Among samples
with the preliminary defined time of HIV infection the
accuracy of testing was: 93.3% - for recent (up to 9
months), 97.8% - for long-standing infection (9 month
and more). All serum samples with late-stage infection
(low CD4+ T cell count) were determined correctly.
Conclusion
Our data demonstrated high efficiency of the kit DS-
EIA-HIV-AB-TERM to identify both recently acquired
and long-standing infection among samples from HIV
type 1 seropositive persons.
Authors’ details
1RPC “Diagnostic Systems”, Nizhny Novgorod, Russia. 2DSI S.r.l. Saronno (VA),
Italy. 3Krasnoyarsk Regional Center of AIDS Prevention, Krasnoyarsk, Russia.
Published: 23 May 2014
doi:10.1186/1471-2334-14-S2-P70
Cite this article as: Zagryadskaya et al.: Assessment of the ability
DS-EIA-HIV-AB-TERM assay correctly identify long-standing and recent
HIV infection. BMC Infectious Diseases 2014 14(Suppl 2):P70.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit1RPC “Diagnostic Systems”, Nizhny Novgorod, Russia
Full list of author information is available at the end of the article
Zagryadskaya et al. BMC Infectious Diseases 2014, 14(Suppl 2):P70
http://www.biomedcentral.com/1471-2334/14/S2/P70
© 2014 Zagryadskaya et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
